Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial

International Journal of Cardiology

Volumn 130, Issue 3, 2008, Pages 457-462

  Leone, Antonio Maria ^a   Rutella, Sergio ^a   Giannico, Maria Benedetta ^a   Perfetti, Matteo ^a   Zaccone, Vincenzo ^a   Brugaletta, Salvatore ^a   Garramone, Barbara ^a   Niccoli, Giampaolo ^a   Porto, Italo ^a   Liuzzo, Giovanna ^a   Biasucci, Luigi Marzio ^a   Bellesi, Silvia ^a   Galiuto, Leonarda ^a   Leone, Giuseppe ^a   Rebuzzi, Antonio Giuseppe ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Acute myocardial infarction; Endothelial Progenitor Cells; Statins

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLEEDING; CD34 SELECTION; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE; INTERMETHOD COMPARISON; MALE; PATIENT MOBILITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGENERATION; ST SEGMENT ELEVATION; STEM CELL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CELL COUNT; COMBINED MODALITY THERAPY; ENDOTHELIAL CELLS; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PYRROLES; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 55549091702     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.05.036     Document Type: Article

References (18)

1. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
2. Cannon C.P., Braunwald E., McCabe C.H., et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. N Engl J Med 8 (2004) 1495-1504
3. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
4. Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al. Myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) study investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285 (2001) 1711-1718
5. Cannon C.P., Braunwald E., McCabe C.H., et al. Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350 (2004) 1495-1504 Erratum in: N Engl J Med 2006;354:778
6. Vasa M., Fichtlscherer S., Adler K., et al. Increase in Circulating Endothelial Progenitor Cells by statin therapy in patients with stable coronary artery disease. Circulation 103 (2001) 2885-2890
7. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007
8. Leone A.M., Rutella S., Bonanno G., et al. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 26 (2005) 1196-1204
9. Wojakowski W., Tendera M., Zebzda A., et al. Mobilization of CD34(+), CD117(+), CXCR4(+), c-met(+) stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction. Eur Heart J 27 (2006) 283-289
10. Badorff C., Brandes R.P., Popp R., et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107 (2003) 1024-1032
11. Urbich C., Aicher A., Heeschen C., et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 39 (2005) 733-742
12. George J., Shmilovich H., Deutsch V., Miller H., Keren G., and Roth A. Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng 12 (2006) 1-5
13. Dimmeler S., Aicher A., Vasa M., et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108 (2001) 391-397
14. Assmus A., Urbich C., Aicher A., et al. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res 92 (2003) 1049-1055
15. Rupp S., Badorff C., Koyanagi M., et al. Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells. Basic Res Cardiol 99 (2004) 61-68
16. Hristov M., Fach C., Becker C., et al. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis 192 (2007) 413-420
17. Leone A.M., Galiuto L., Rutella S., et al. Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study). Heart 92 (2006) 1850-1851
18. Leone A.M., Galiuto L., Garramone B., et al. Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the Rigenera study). Am J Cardiol 100 (2007) 397-403